Neonatal abstinence syndrome
GPTKB entity
Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical condition
|
| gptkbp:affects |
newborns
|
| gptkbp:alsoKnownAs |
gptkb:NAS
|
| gptkbp:cause |
developmental delays
prolonged hospitalization |
| gptkbp:causedBy |
maternal drug use during pregnancy
|
| gptkbp:complication |
maternal substance use disorder
|
| gptkbp:diagnosedBy |
clinical assessment
Finnegan scoring system |
| gptkbp:firstDescribed |
1970s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Neonatal abstinence syndrome
|
| gptkbp:ICD-10_code |
P96.1
|
| gptkbp:MeSH_ID |
D009358
|
| gptkbp:monitors |
gptkb:hospital
|
| gptkbp:prevalence |
increasing in the United States
|
| gptkbp:prevention |
maternal substance use treatment
|
| gptkbp:relatedTo |
gptkb:fetal_alcohol_syndrome
perinatal drug exposure |
| gptkbp:riskFactor |
antidepressant use in pregnancy
benzodiazepine use in pregnancy opioid use in pregnancy |
| gptkbp:symptom |
vomiting
diarrhea seizures irritability feeding difficulties tremors poor weight gain excessive crying |
| gptkbp:treatment |
gptkb:methadone
gptkb:morphine gptkb:buprenorphine supportive care pharmacologic therapy |
| gptkbp:bfsParent |
gptkb:Opiate
|
| gptkbp:bfsLayer |
5
|